Evidence map›Paper›PMID 34443626›Full record

ArticleMolecules (Basel, Switzerland)2021

Melatonin Induces Autophagy via Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress Pathway in Colorectal Cancer Cells.

Kian Chung Chok, Rhun Yian Koh, Ming Guan Ng, Pei Ying Ng, Soi Moi Chye

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Melatonin: A Potential Regulator of DNA Methylation.Antioxidants (Basel, Switzerland) · 2023
    Review
  12. Review
  13. Review
  14. Redox Active Molecules in Cancer Treatments.Molecules (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Use of Melatonin in Cancer Treatment: Where Are We?International journal of molecular sciences · 2022
    Review
  20. Nanotechnology Frontiers in γ-Herpesviruses Treatments.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kian Chung ChokSchool of Health Science, International Medical University, Kuala Lumpur 57000, Malaysia.ORCID 0000-0002-1440-4861
Rhun Yian KohDivision of Biomedical Science and Biotechnology, School of Health Science, International Medical University, Kuala Lumpur 57000, Malaysia.
Ming Guan NgSchool of Health Science, International Medical University, Kuala Lumpur 57000, Malaysia.
Pei Ying NgSchool of Postgraduate, International Medical University, Kuala Lumpur 57000, Malaysia.
Soi Moi ChyeDivision of Biomedical Science and Biotechnology, School of Health Science, International Medical University, Kuala Lumpur 57000, Malaysia.
IMU University · MY

Funding

International Medical University BMSc I-2020 (08), BMSc I-2019 (02) and BMSc I-2018 (09)
6 · The paper itself

Abstract

Even though an increasing number of anticancer treatments have been discovered, the mortality rates of colorectal cancer (CRC) have still been high in the past few years. It has been discovered that melatonin has pro-apoptotic properties and counteracts inflammation, proliferation, angiogenesis, cell invasion, and cell migration. In previous studies, melatonin has been shown to have an anticancer effect in multiple tumors, including CRC, but the underlying mechanisms of melatonin action on CRC have not been fully explored. Thus, in this study, we investigated the role of autophagy pathways in CRC cells treated with melatonin. In vitro CRC cell models, HT-29, SW48, and Caco-2, were treated with melatonin. CRC cell death, oxidative stress, and autophagic vacuoles formation were induced by melatonin in a dose-dependent manner. Several autophagy pathways were examined, including the endoplasmic reticulum (ER) stress, 5'-adenosine monophosphate-activated protein kinase (AMPK), phosphoinositide 3-kinase (PI3K), serine/threonine-specific protein kinase (Akt), and mammalian target of rapamycin (mTOR) signaling pathways. Our results showed that melatonin significantly induced autophagy via the ER stress pathway in CRC cells. In conclusion, melatonin demonstrated a potential as an anticancer drug for CRC.

Indexed as

AMP-Activated Protein KinasesAntineoplastic AgentsApoptosisAutophagyCaco-2 CellsCell Line, TumorColorectal NeoplasmsEndoplasmic Reticulum StressHT29 CellsHumansMelatoninPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesSignal TransductionTOR Serine-Threonine KinasesAMP-Activated Protein KinasesAntineoplastic AgentsMelatoninPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesTOR Serine-Threonine Kinasesautophagycolorectal cancer cellsendoplasmic reticulum stressmelatoninreactive oxygen species

Identifiers

PMID34443626
PMCPMC8400139
OpenAlexW3193948731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.